Solid tumor webinars

Flexible, sensitive EGFR mutation testing in NSCLC

Join Scott Markland to learn about the role of EGFR in non-small cell lung cancer, including the changing mutational landscape of EGFR testing in response to treatment with targeted therapies. Then, discover how testing with the therascreen EGFR Plus RGQ PCR Kit can benefit you and your NSCLC patients.

KRAS G12C in lung cancer treatment decisions

Dr. Anjen Chenn discusses the importance of testing for KRAS G12C in non-small cell lung cancer (NSCLC) patients in order to prescribe the targeted therapy LUMAKRAS.

FGFR testing in urothelial cancer

Examine the significance of FGFR alterations and discover how FGFR testing can be leveraged to identify patients who may be eligible for treatment with erdafitinib.

Testing for PIK3CA mutations in advanced breast cancer

Join Dr. Lawrence Weiss to learn more about the importance of using both tissue and plasma companion diagnostics in testing for PIK3CA mutations in advanced breast cancer.

Accelerate your NGS workflows

In this webinar, learn how advances in QIAseq chemistry can help accelerate your NGS workflows.

Comparison of methods in routine somatic diagnostics

Dr. Mattia Schmid from UniLabs, Switzerland compares the methods of molecular oncology testing used in his laboratory and shows the results from a trial of a new method.

HRR and HRD: The role of DNA damage repair

Join Dr. Raed Samara and Dr. Vikas Gupta to explore the role of homogous recombination repair and deficiency in DNA damage repair.

Comprehensive genomic profiling or targeted NGS panels – a place for both?

Join Dr. Andrea Ferreira-Gonzalez, Dr. Ravindra Kolhe, Dr. Pauline Rehal, Dr. Peter Wild and Dr. Davide Manissero (Moderator) for this interesting and insightful panel discussion.